SYLVANT 400 mg subst sèche flac perf 1 pce

7680651830022 CH-65183 L04AC11 07.16.1.
SYLVANT 400 mg subst sèche flac perf  1 pce
SYLVANT 400 mg subst sèche flac perf  1 pce
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6518302
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: siltuximabum 420 mg, saccharum, histidini hydrochloridum monohydricum aut histidinum, polysorbatum 80, pro vitro.

Articles (1)

Sylvant 400 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
04/11/2025
Professional SmPC
Français
04/11/2025
Professional SmPC
Italien
04/11/2025

Detailed composition

Substance Quantity Type Category
siltuximabum
420.0 MG Substance Wirkstoff (Principe actif)
saccharum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
histidinum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
65183
Drug name
Sylvant, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Galenic form
PULPA
ATC Code
L04AC11
Authorization status
Z
Dispensation category
A
First authorization
17/12/2014
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Castleman-Krankheit

Packaging details

Description (FR)
SYLVANT 400 mg subst sèche flac perf 1 pce
Description (DE)
SYLVANT 400 mg Trockensub Durchstf 1 Stk
Market launch
17/12/2014
Narcotic (BTM)
No

Other packaging sizes

SYLVANT 100 mg subst sèche flac perf 1 pce
1 DUR
View
Buy us a coffee Explore the data